TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS
TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS
复制标题
DOI:
--
复制
发表时间:
1996
期刊:
影响因子:
--
通讯作者:
Kerry L. Lee;Daniel B. Mark
中科院分区:
文献类型:
--
作者:
Kerry L. Lee;Daniel B. Mark
SUMMARY Multivariable regression models are powerful tools that are used frequently in studies of clinical outcomes. These models can use a mixture of categorical and continuous variables and can handle partially observed (censored) responses. However, uncritical application of modelling techniques can result in models that poorly fit the dataset at hand, or, even more likely, inaccurately predict outcomes on new subjects. One must know how to measure qualities of a model's fit in order to avoid poorly fitted or overfitted models. Measurement of predictive accuracy can be difficult for survival time data in the presence of censoring. We discuss an easily interpretable index of predictive discrimination as well as methods for assessing calibration of predicted survival probabilities. Both types of predictive accuracy should be unbiasedly validated using bootstrapping or cross-validation, before using predictions in a new data series. We discuss some of the hazards of poorly fitted and overfitted regression models and present one modelling strategy that avoids many of the problems discussed. The methods described are applicable to all regression models, but are particularly needed for binary, ordinal, and time-to-event outcomes. Methods are illustrated with a survival analysis in prostate cancer using Cox regression. Accurate estimation of patient prognosis is important for many reasons. First, prognostic estimates can be used to inform the patient about likely outcomes of her disease. Second, the physician can use estimates of prognosis as a guide for ordering additional tests and selecting appropriate therapies. Third, prognostic assessments are useful in the evaluation of technologies; prognostic estimates derived both with and without using the results of a given test can be compared to measure the incremental prognostic information provided by that test over what is provided by prior information.' Fourth, a researcher may want to estimate the effect of a single factor (for example, treatment given) on prognosis in an observational study in which many uncontrolled confounding factors are also measured. Here the simultaneous effects of the uncontrolled variables must be controlled (held constant mathematically if using a regression model) so that the effect of the factor of interest can be more purely estimated. An analysis of how variables (especially continuous ones) affect the patient outcomes of interest is necessary to